Paid Clinical Trials in Erie, PA
As of August 2026, 84 paid clinical trials are recruiting in Erie, Pennsylvania. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Erie offers studies at sites including UPMC Hillman Cancer Center Erie for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Amblyopia, Diabetic Macular Edema, Geographic Atrophy. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Erie
Trials by drug in Erie
Filter results
79 clinical trials
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Study of ALK-001 on the Progression of Stargardt Disease
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Top Research Study Locations in Erie
Researchers run research studies in Erie, PA at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UPMC Hillman Cancer Center Erie | Anatomic Stage II Breast Cancer AJCC v8, Head and Neck Squamous Cell Carcinoma, Recurrent Endometrial Carcinoma | 40 |
| Saint Vincent Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 14 |
| Erie Retina Research | Geographic Atrophy, Macular Degeneration, Age-Related Macular Degeneration | 14 |
| Pediatric Ophthalmology of Erie | Amblyopia | 3 |
| Allegheny Health and Wellness Pavilion | Lyme Disease, Pneumococcal Disease | 2 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Allegheny St. Vincent Hospital | Deep Venous Thrombosis, Post-Thrombotic Syndrome, Venous Thromboembolism | 1 |
| CBCC Global Research Site:002 | Age-related Wet Macular Degeneration | 1 |
| Central Erie Primary Care | Lyme Disease | 1 |
| Erie | Endometriosis, Uterine Fibroids | 1 |
| Erie Retina Research LLC | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Erie Retina Research, LLC | Center Involved Diabetic Macular Edema, Diabetic Macular Edema | 1 |
| Erie Retina Research, LLC (Clinic) | Age - Related Macular Degeneration (AMD), Geographic Atrophy (GA) | 1 |
| Erie Retina Research, LLC - 300 State St | Diabetic Macular Edema | 1 |
| Erie Retinal Surgery & Erie Retina Research | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA) | 1 |
| Erie, PA | Neovascular (Wet) Age-Related Macular Degeneration | 1 |
| Greater Erie Surgery Center | Lumbar Spinal Stenosis | 1 |
| Greater Erie Surgery Center, LLC | Lumbar Spinal Stenosis | 1 |
| Kriya Clinical Study Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| OB/GYN Associates of Erie | Urinary Incontinence,Stress | 1 |
| OBGYN Associates of Erie | Functional Hypothalamic Amenorrhea (FHA) | 1 |
| Penn State Univercity | Anxiety, Depression, Stress | 1 |
| PennState the Beherend College/VAR Lab | Well-Being, Psychological | 1 |
| Plaza 38 Medical Offices | No Disease or Condition is Being Directly Studied, The Focus of the Study in Healthy Volunteers | 1 |
Active & Upcoming Studies in Erie (2026)
Recruiting trials in Erie grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (43 active studies)
- Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer · Phase 2 · National Cancer Institute (NCI)
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
Eye & vision (20 active studies)
- Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration · Phase 1, Phase 2 · Eyconis INC.
- A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) · Phase 1 · Genentech, Inc.
Mental health & behavior (2 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Assessing the Impact of VR-Based Observational Mindfulness Meditation on Stress Reduction in Adults · Penn State University
Cardiovascular (2 active studies)
Vaccines (1 active study)
Common conditions studied in Erie
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Amblyopia (3 active studies)
- Diabetic Macular Edema (3 active studies)
- Geographic Atrophy (3 active studies)
- Head and Neck Squamous Cell Carcinoma (3 active studies)
- Macular Degeneration (3 active studies)
Leading research sponsors in Erie
- National Cancer Institute (NCI)
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Erie?
There are approximately 84 recruiting clinical trials in Erie, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Erie pay participants?
Most recruiting trials in Erie compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Erie?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Erie?
The most common conditions under active study in Erie include Anatomic Stage II Breast Cancer AJCC v8 (4), Amblyopia (3), Diabetic Macular Edema (3), Geographic Atrophy (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Erie?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Erie on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Erie?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Erie?
Recruiting research sites in Erie include UPMC Hillman Cancer Center Erie, Saint Vincent Hospital, Erie Retina Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Erie right now?
The largest active categories in Erie are Cancer & tumors (43), Eye & vision (20), Mental health & behavior (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.